期刊文献+

生物活性小分子的靶标鉴定 被引量:1

Target identification of bioactive small molecules
原文传递
导出
摘要 生物活性小分子靶标的明确鉴定需要整合多种分析方法,从多层次、多角度阐明其作用靶标的有效性和专属性。即使这样也都无法排除假阳性或者假阴性的产生,只有各种方法联用才能有力阐明小分子的生物活性与相应靶标。本文系统综述了生物活性小分子靶标鉴定与验证的方法,总结为直接法(包括生物素亲和标签、亲和胶、噬菌体展示、光交联法、亲和磁珠法等)和间接法(包括药物亲和反应靶标分析、蛋白质组学分析、化学基因组学分析和代谢组学分析等)两种。每种方法分别列举了1个实例,并讨论了其优势和劣势,以明确其适用范围和应用前景。 The identification and validation of targets for bioactive small molecules need to integrate a vari- ety of analytical methods. The effectiveness and specificity can be confirmed from multi-level and multi-angle. Even so it cannot rule out false positive or false negative results, and only by using a combination of these methods can make it as effectively as possible to illustrate the biological activity and corresponding targets of bioactive small mol- ecules. Target identification and validation methods of these molecules were systematically summarized in this pa- per, including direct methods (biotin-affinity tag, affi-gel tag, phage display, photo-crosslink and high perform- ance affinity magnetic beads) and indirect methods ( drug affinity responsive target stability, proteomic profiling and chemical-genetic profiling). One example was given to illustrate each method, and the advantages and disadvanta- ges were discussed to clarify its application and prospect.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第10期1119-1123,共5页 Chinese Journal of New Drugs
基金 国家自然科学基金(81273474 81202496) 上海市中药现代化基金(12401900802)
关键词 生物活性小分子 靶标鉴定 直接法 间接法 整合 bioactive small molecules target identification direct methods indirect methods integrate
  • 相关文献

参考文献37

  • 1VOGL S, ATANASOV AG, BINDER M, et al. The Herbal Drug Melampyrum pratense L. (Koch) :Isolation and Identification of Its Bioactive Compounds Targeting Mediators of Inflammation [J]. Evid Based Complement Alternat Med,2013 :395316.
  • 2TASHIRO E, IMOTO M. Target identification of bioactive com- pounds[J]. Bioorgan Med Chem,2012,20( 6 ) :1910 -1921.
  • 3TIIOV DV,LIU JO. Identification and validation of protein targets of bioactive small molecules [ J ]. Bioorgan Med Chem,2012,20 (6) :1902 - 1909.
  • 4CALLERI E, TEMPORINI C, CACCIALANZA G, et al. Target- based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry [ J ]. Chem Med Chem, 2009,4 ( 6 ) :905 - 916.
  • 5LIM KH, HUANG H, PRALLE A, et al. Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection [ J ]. Biotechnol Bioeng,2013,110 ( 1 ) : 57 - 67.
  • 6KOTAKE Y,SAGANE K,OWA T,et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide[J]. Nat Chem Biol,2007,3 (9) :570 - 575.
  • 7YANG J,SHAMJI A, MATCHACHEEP S,et al. Identification of a small-molecule inhibitor of class Ia PI3Ks with cell-based screening[ J ]. Chem Bio1,2007,14 (4) :37 1 - 377.
  • 8PANDE J, SZEWCZYK M, GROVER AK. Phage display: con- cept,innovations, applications and future [ J ]. Biotechnol Adv, 2010,28(6) :849 -858.
  • 9SIDHU SS,KOIDE S. Phage display for engineering and analy-zing protein interaction interfaces [ J ]. Curr Opin Struc Biol, 2007,17(4) :481 -487.
  • 10JUNG HJ,SHIM JS,LEE J,et al. Terpestacin inhibits tumor an- giogenesis by targeting UQCRB of mitochondrial complex IIl and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing [ J ]. J Biol Chem, 2010,285 ( 15 ) : 11584 - 11595.

同被引文献8

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部